Related references
Note: Only part of the references are listed.DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions
Dimitra Karagkouni et al.
NUCLEIC ACIDS RESEARCH (2018)
Role of micro-RNAs in breast cancer surgery
P. McAnena et al.
BRITISH JOURNAL OF SURGERY (2018)
Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors
Artur Kowalik et al.
TRANSLATIONAL RESEARCH (2017)
Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer
Maire-Caitlin Casey et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment
Oleg Gluz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia
Aleksandra Butrym et al.
ONCOLOGY LETTERS (2016)
Diverse human extracellular RNAs are widely detected in human plasma
Jane E. Freedman et al.
NATURE COMMUNICATIONS (2016)
Discordant Expression of Circulating microRNA from Cellular and Extracellular Sources
Ravi Shah et al.
PLOS ONE (2016)
Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase
D. Di Gioia et al.
BRITISH JOURNAL OF CANCER (2015)
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
Andrew McGuire et al.
CANCER AND METASTASIS REVIEWS (2015)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1
Richa Singh et al.
SCIENTIFIC REPORTS (2015)
The roles of microRNAs in the regulation of tumor metastasis
Lei Zhou et al.
CELL AND BIOSCIENCE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2
Ping Huang et al.
TUMOR BIOLOGY (2015)
miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A
Haifeng Yang et al.
FEBS LETTERS (2014)
MicroRNA-331-3p Promotes Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting PH Domain and Leucine-Rich Repeat Protein Phosphatase
Rui-Min Chang et al.
HEPATOLOGY (2014)
MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1
Dengbo Ji et al.
MOLECULAR CANCER (2014)
Biological subtypes of breast cancer: Prognostic and therapeutic implications
Ozlem Yersal et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
Mario Giuliano et al.
BREAST CANCER RESEARCH (2014)
Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells
Jean-Charles Neel et al.
CELLULAR SIGNALLING (2013)
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
N. Harbeck et al.
EUROPEAN JOURNAL OF CANCER (2013)
Circulating microRNAs in plasma as early detection markers for breast cancer
Katarina Cuk et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
TGF-beta upregulates miR-181a expression to promote breast cancer metastasis
Molly A. Taylor et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma
A. Bhattacharya et al.
ONCOGENE (2013)
Identification and Validation of miRNAs as Endogenous Controls for RQ-PCR in Blood Specimens for Breast Cancer Studies
Ailbhe M. McDermott et al.
PLOS ONE (2013)
Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells
Yiwei Lin et al.
FEBS LETTERS (2012)
Downregulation of BCL2 by miRNAs augments drug-induced apoptosis - a combined computational and experimental approach
Richa Singh et al.
JOURNAL OF CELL SCIENCE (2012)
MicroRNA profiling: approaches and considerations
Colin C. Pritchard et al.
NATURE REVIEWS GENETICS (2012)
Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
Dan Li et al.
CLINICAL CANCER RESEARCH (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Helen M. Heneghan et al.
ANNALS OF SURGERY (2010)
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Nobuyoshi Kosaka et al.
CANCER SCIENCE (2010)
CA 15-3: Uses and limitation as a biomarker for breast cancer
Michael J. Duffy et al.
CLINICA CHIMICA ACTA (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
MicroRNA-195 Suppresses Tumorigenicity and Regulates G1/S Transition of Human Hepatocellular Carcinoma Cells
Teng Xu et al.
HEPATOLOGY (2009)
Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer
Pamela A. Davoren et al.
BMC MOLECULAR BIOLOGY (2008)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system
A. E. Erson et al.
CLINICAL GENETICS (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
Tumour marker guided salvage treatment prolongs survival of breast cancer patients: final report of a 7-year study
A Nicolini et al.
BIOMEDICINE & PHARMACOTHERAPY (2003)
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1
F Jänicke et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
